Ken Fisher Arrowhead Pharmaceuticals, Inc. Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q4 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 142,939 shares of ARWR stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142,939
Previous 122,260
16.91%
Holding current value
$1.61 Million
Previous $2.37 Million
13.57%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
303Shares Held
95.8MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$176 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$137 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$125 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$67.6 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$58.8 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.19B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...